{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T08:08:20Z","timestamp":1790755700553,"version":"4.1.0"},"reference-count":97,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,23]],"date-time":"2023-10-23T00:00:00Z","timestamp":1698019200000},"content-version":"vor","delay-in-days":22,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R01NS115815"],"award-info":[{"award-number":["R01NS115815"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R01NS102589"],"award-info":[{"award-number":["R01NS102589"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018553","name":"Chuck Noll Foundation for Brain Injury Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018553","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009797","name":"Barrow Neurological Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009797","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["neurotherapeuticsjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurotherapeutics"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1007\/s13311-023-01389-x","type":"journal-article","created":{"date-parts":[[2023,6,12]],"date-time":"2023-06-12T11:02:54Z","timestamp":1686567774000},"page":"1472-1481","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Glibenclamide for Brain Contusions: Contextualizing a Promising Clinical Trial Design that Leverages an Imaging-Based TBI Endotype"],"prefix":"10.1016","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3047-7649","authenticated-orcid":false,"given":"Ruchira M.","family":"Jha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Marc","family":"Simard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1007\/s13311-023-01389-x_bib1","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/S1474-4422(17)30371-X","article-title":"Traumatic brain injury: integrated approaches to improve prevention, clinical care, and research","volume":"16","author":"Maas","year":"2017","journal-title":"Lancet Neurol"},{"key":"10.1007\/s13311-023-01389-x_bib2","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1056\/NEJMoa1507581","article-title":"Hypothermia for intracranial hypertension after traumatic brain injury","volume":"373","author":"Andrews","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1007\/s13311-023-01389-x_bib3","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1016\/S0140-6736(04)17188-2","article-title":"Effect of intravenous corticosteroids on death within 14 days in 10008 adults with clinically significant head injury (MRC CRASH trial): randomised placebo-controlled trial","volume":"364","author":"Roberts","year":"2004","journal-title":"Lancet"},{"key":"10.1007\/s13311-023-01389-x_bib4","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1016\/S0140-6736(05)66552-X","article-title":"Final results of MRC CRASH, a randomised placebo-controlled trial of intravenous corticosteroid in adults with head injury-outcomes at 6 months","volume":"365","author":"Edwards","year":"2005","journal-title":"Lancet"},{"key":"10.1007\/s13311-023-01389-x_bib5","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S1474-4422(10)70300-8","article-title":"Very early hypothermia induction in patients with severe brain injury (the National Acute Brain Injury Study: Hypothermia II): a randomised trial","volume":"10","author":"Clifton","year":"2011","journal-title":"Lancet Neurol"},{"key":"10.1007\/s13311-023-01389-x_bib6","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S1474-4422(06)70630-5","article-title":"Magnesium sulfate for neuroprotection after traumatic brain injury: a randomised controlled trial","volume":"6","author":"Temkin","year":"2007","journal-title":"Lancet Neurol"},{"key":"10.1007\/s13311-023-01389-x_bib7","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1056\/NEJMoa1404304","article-title":"Very early administration of progesterone for acute traumatic brain injury","volume":"371","author":"Wright","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1007\/s13311-023-01389-x_bib8","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1016\/S0140-6736(15)00386-4","article-title":"Erythropoietin in traumatic brain injury (EPO-TBI): a double-blind randomised controlled trial","volume":"386","author":"Nichol","year":"2015","journal-title":"Lancet"},{"key":"10.1007\/s13311-023-01389-x_bib9","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1056\/NEJMe1412951","article-title":"Progesterone for traumatic brain injury\u2013resisting the sirens' song","volume":"371","author":"Schwamm","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1007\/s13311-023-01389-x_bib10","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/S1474-4422(17)30225-9","article-title":"Adding insight to injury: a new era in neurotrauma","volume":"16","author":"Jha","year":"2017","journal-title":"Lancet Neurol"},{"key":"10.1007\/s13311-023-01389-x_bib11","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S1474-4422(21)00374-4","article-title":"Effect of frailty on 6-month outcome after traumatic brain injury: a multicentre cohort study with external validation","volume":"21","author":"Galimberti","year":"2022","journal-title":"Lancet Neurol"},{"key":"10.1007\/s13311-023-01389-x_bib12","doi-asserted-by":"crossref","first-page":"343","DOI":"10.3389\/fneur.2019.00343","article-title":"Pre-injury comorbidities are associated with functional impairment and post-concussive symptoms at 3- and 6-months after mild traumatic brain injury: a TRACK-TBI study","volume":"10","author":"Yue","year":"2019","journal-title":"Front Neurol"},{"key":"10.1007\/s13311-023-01389-x_bib13","doi-asserted-by":"crossref","first-page":"E88","DOI":"10.1097\/HTR.0000000000000798","article-title":"Associations of preexisting vascular risk factors with outcomes after traumatic brain injury: a TRACK-TBI study","volume":"38","author":"Schneider","year":"2023","journal-title":"J Head Trauma Rehabil"},{"key":"10.1007\/s13311-023-01389-x_bib14","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1089\/neu.2013.2984","article-title":"Symptomatology and functional outcome in mild traumatic brain injury: results from the prospective TRACK-TBI study","volume":"31","author":"McMahon","year":"2014","journal-title":"J Neurotrauma"},{"key":"10.1007\/s13311-023-01389-x_bib15","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1227\/NEU.0000000000001432","article-title":"Guidelines for the management of severe traumatic brain injury, fourth edition","volume":"80","author":"Carney","year":"2017","journal-title":"Neurosurgery"},{"key":"10.1007\/s13311-023-01389-x_bib16","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/S1474-4422(17)30118-7","article-title":"Severe traumatic brain injury: targeted management in the intensive care unit","volume":"16","author":"Stocchetti","year":"2017","journal-title":"Lancet Neurol"},{"key":"10.1007\/s13311-023-01389-x_bib17","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s11910-018-0912-9","article-title":"A precision medicine approach to cerebral edema and intracranial hypertension after severe traumatic brain injury: quo vadis?","volume":"18","author":"Jha","year":"2018","journal-title":"Curr Neurol Neurosci Rep"},{"key":"10.1007\/s13311-023-01389-x_bib18","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.neuropharm.2018.08.004","article-title":"Pathophysiology and treatment of cerebral edema in traumatic brain injury","volume":"145","author":"Jha","year":"2019","journal-title":"Neuropharmacology"},{"key":"10.1007\/s13311-023-01389-x_bib19","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1001\/jama.2018.17075","article-title":"Effect of early sustained prophylactic hypothermia on neurologic outcomes among patients with severe traumatic brain injury: the POLAR randomized clinical trial","volume":"320","author":"Cooper","year":"2018","journal-title":"JAMA"},{"key":"10.1007\/s13311-023-01389-x_bib20","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1056\/NEJMoa1207363","article-title":"A trial of intracranial-pressure monitoring in traumatic brain injury","volume":"367","author":"Chesnut","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1007\/s13311-023-01389-x_bib21","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/B978-0-444-52892-6.00002-7","article-title":"Classification of traumatic brain injury: past, present, and future","volume":"127","author":"Hawryluk","year":"2015","journal-title":"Handb Clin Neurol"},{"key":"10.1007\/s13311-023-01389-x_bib22","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/S1474-4422(22)00309-X","article-title":"Traumatic brain injury: progress and challenges in prevention, clinical care, and research","volume":"21","author":"Maas","year":"2022","journal-title":"Lancet Neurol"},{"key":"10.1007\/s13311-023-01389-x_bib23","doi-asserted-by":"crossref","first-page":"5","DOI":"10.2337\/dc19-0880","article-title":"Introducing the endotype concept to address the challenge of disease heterogeneity in type 1 diabetes","volume":"43","author":"Battaglia","year":"2020","journal-title":"Diabetes Care"},{"key":"10.1007\/s13311-023-01389-x_bib24","doi-asserted-by":"crossref","DOI":"10.1007\/s12028-022-01475-6","article-title":"Endotypes and the path to precision in moderate and severe traumatic brain injury","author":"Azad","year":"2022","journal-title":"Neurocrit Care"},{"key":"10.1007\/s13311-023-01389-x_bib25","doi-asserted-by":"crossref","first-page":"2460","DOI":"10.1089\/neu.2020.7140","article-title":"Point-of-care platform blood biomarker testing of glial fibrillary acidic protein versus S100 calcium-binding protein B for prediction of traumatic brain injuries: a transforming research and clinical knowledge in traumatic brain injury study","volume":"37","author":"Okonkwo","year":"2020","journal-title":"J Neurotrauma"},{"key":"10.1007\/s13311-023-01389-x_bib26","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1089\/neu.2017.5182","article-title":"Blood-based protein biomarkers for the management of traumatic brain injuries in adults presenting to emergency departments with mild brain injury: a living systematic review and meta-analysis","volume":"38","author":"Mondello","year":"2021","journal-title":"J Neurotrauma"},{"key":"10.1007\/s13311-023-01389-x_bib27","doi-asserted-by":"crossref","DOI":"10.1002\/ams2.622","article-title":"Thorough overview of ubiquitin C-terminal hydrolase-L1 and glial fibrillary acidic protein as tandem biomarkers recently cleared by US Food and Drug Administration for the evaluation of intracranial injuries among patients with traumatic brain injury","volume":"8","author":"Wang","year":"2021","journal-title":"Acute Med Surg"},{"key":"10.1007\/s13311-023-01389-x_bib28","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/S1474-4422(22)00218-6","article-title":"Incremental prognostic value of acute serum biomarkers for functional outcome after traumatic brain injury (CENTER-TBI): an observational cohort study","volume":"21","author":"Helmrich","year":"2022","journal-title":"Lancet Neurol"},{"key":"10.1007\/s13311-023-01389-x_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2021.103777","article-title":"Relationship of admission blood proteomic biomarkers levels to lesion type and lesion burden in traumatic brain injury: A CENTER-TBI study","volume":"75","author":"Whitehouse","year":"2022","journal-title":"EBioMedicine"},{"key":"10.1007\/s13311-023-01389-x_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2020.102785","article-title":"Blood biomarkers on admission in acute traumatic brain injury: relations to severity, CT findings and care path in the CENTER-TBI study","volume":"56","author":"Czeiter","year":"2020","journal-title":"EBioMedicine"},{"key":"10.1007\/s13311-023-01389-x_bib31","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1227\/NEU.0000000000001776","article-title":"Blood biomarkers and structural imaging correlations post-traumatic brain injury: a systematic review","volume":"90","author":"Whitehouse","year":"2022","journal-title":"Neurosurgery"},{"key":"10.1007\/s13311-023-01389-x_bib32","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/S1474-4422(19)30282-0","article-title":"Association between plasma GFAP concentrations and MRI abnormalities in patients with CT-negative traumatic brain injury in the TRACK-TBI cohort: a prospective multicentre study","volume":"18","author":"Yue","year":"2019","journal-title":"Lancet Neurol"},{"key":"10.1007\/s13311-023-01389-x_bib33","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1007\/s12028-020-00994-4","article-title":"Contusion progression following traumatic brain injury: a review of clinical and radiological predictors, and influence on outcome","volume":"34","author":"Adatia","year":"2021","journal-title":"Neurocrit Care"},{"key":"10.1007\/s13311-023-01389-x_bib34","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.16839","article-title":"Genetic variants associated with intraparenchymal hemorrhage progression after traumatic brain injury","volume":"4","author":"Jha","year":"2021","journal-title":"JAMA Netw Open"},{"key":"10.1007\/s13311-023-01389-x_bib35","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21020409","article-title":"Role of sulfonylurea receptor 1 and glibenclamide in traumatic brain injury: a review of the evidence","volume":"21","author":"Jha","year":"2020","journal-title":"Int J Mol Sci."},{"key":"10.1007\/s13311-023-01389-x_bib36","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1080\/01616412.2018.1505416","article-title":"Temporal lobe contusions on computed tomography are associated with impaired 6-month functional recovery after mild traumatic brain injury: a TRACK-TBI study","volume":"40","author":"Yue","year":"2018","journal-title":"Neurol Res"},{"key":"10.1007\/s13311-023-01389-x_bib37","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1089\/neu.2007.0385","article-title":"Progression of traumatic intracerebral hemorrhage: a prospective observational study","volume":"25","author":"Narayan","year":"2008","journal-title":"J Neurotrauma"},{"key":"10.1007\/s13311-023-01389-x_bib38","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1089\/neu.2011.2122","article-title":"Hemorrhagic progression of a contusion after traumatic brain injury: a review","volume":"29","author":"Kurland","year":"2012","journal-title":"J Neurotrauma"},{"key":"10.1007\/s13311-023-01389-x_bib39","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3171\/jns.2002.96.1.0109","article-title":"Progressive hemorrhage after head trauma: predictors and consequences of the evolving injury","volume":"96","author":"Oertel","year":"2002","journal-title":"J Neurosurg"},{"key":"10.1007\/s13311-023-01389-x_bib40","first-page":"70","article-title":"The value of the \u201cworst\u201d computed tomographic scan in clinical studies of moderate and severe head injury","volume":"46","author":"Servadei","year":"2000","journal-title":"European Brain Injury Consortium. Neurosurgery"},{"key":"10.1007\/s13311-023-01389-x_bib41","first-page":"959","article-title":"Abnormal coagulation tests are associated with progression of traumatic intracranial hemorrhage","volume":"67","author":"Allard","year":"2009","journal-title":"J Trauma"},{"key":"10.1007\/s13311-023-01389-x_bib42","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1089\/neu.2009.0986","article-title":"Extended analysis of early computed tomography scans of traumatic brain injured patients and relations to outcome","volume":"27","author":"Nelson","year":"2010","journal-title":"J Neurotrauma"},{"key":"10.1007\/s13311-023-01389-x_bib43","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1089\/neu.2013.3241","article-title":"Early hemorrhagic progression of traumatic brain contusions: frequency, correlation with coagulation disorders, and patient outcome: a prospective study","volume":"31","author":"Juratli","year":"2014","journal-title":"J Neurotrauma"},{"key":"10.1007\/s13311-023-01389-x_bib44","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1227\/00006123-199202000-00002","article-title":"Delayed brain injury after head trauma: significance of coagulopathy","volume":"30","author":"Stein","year":"1992","journal-title":"Neurosurgery"},{"key":"10.1007\/s13311-023-01389-x_bib45","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.3171\/2017.7.JNS17988","article-title":"Blossoming contusions: identifying factors contributing to the expansion of traumatic intracerebral hemorrhage","volume":"129","author":"Carnevale","year":"2018","journal-title":"J Neurosurg"},{"key":"10.1007\/s13311-023-01389-x_bib46","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s00701-016-3043-6","article-title":"Progressive hemorrhagic injury in patients with traumatic intracerebral hemorrhage: characteristics, risk factors and impact on management","volume":"159","author":"Wan","year":"2017","journal-title":"Acta Neurochir (Wien)"},{"key":"10.1007\/s13311-023-01389-x_bib47","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1089\/neu.2014.3808","article-title":"Traumatic intracerebral hemorrhage: risk factors associated with progression","volume":"32","author":"Cepeda","year":"2015","journal-title":"J Neurotrauma"},{"key":"10.1007\/s13311-023-01389-x_bib48","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1089\/neu.2015.4153","article-title":"Contrecoup traumatic intracerebral hemorrhage: a geometric study of the impact site and association with hemorrhagic progression","volume":"33","author":"Cepeda","year":"2016","journal-title":"J Neurotrauma"},{"key":"10.1007\/s13311-023-01389-x_bib49","first-page":"42","article-title":"Hematoma enlargement among patients with traumatic brain injury: analysis of a prospective multicenter clinical trial","volume":"8","author":"Qureshi","year":"2015","journal-title":"J Vasc Interv Neurol"},{"key":"10.1007\/s13311-023-01389-x_bib50","doi-asserted-by":"crossref","first-page":"212","DOI":"10.4103\/jnrp.jnrp_335_18","article-title":"Radiological parameters to predict hemorrhagic progression of traumatic contusional brain injury","volume":"10","author":"Rehman","year":"2019","journal-title":"J Neurosci Rural Pract"},{"key":"10.1007\/s13311-023-01389-x_bib51","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1007\/s12028-016-0303-5","article-title":"Derivation of a predictive score for hemorrhagic progression of cerebral contusions in moderate and severe traumatic brain injury","volume":"26","author":"Allison","year":"2017","journal-title":"Neurocrit Care"},{"key":"10.1007\/s13311-023-01389-x_bib52","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1089\/neu.2014.3697","article-title":"Risk factors for early hemorrhagic progression after traumatic brain injury: a focus on lipid profile","volume":"32","author":"Kim","year":"2015","journal-title":"J Neurotrauma"},{"key":"10.1007\/s13311-023-01389-x_bib53","doi-asserted-by":"crossref","first-page":"908","DOI":"10.3171\/2013.12.JNS131090","article-title":"Patients with brain contusions: predictors of outcome and relationship between radiological and clinical evolution","volume":"120","author":"Iaccarino","year":"2014","journal-title":"J Neurosurg"},{"key":"10.1007\/s13311-023-01389-x_bib54","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.3171\/2009.5.JNS081369","article-title":"The natural history of brain contusion: an analysis of radiological and clinical progression","volume":"112","author":"Alahmadi","year":"2010","journal-title":"J Neurosurg"},{"key":"10.1007\/s13311-023-01389-x_bib55","first-page":"508","article-title":"Early progression of traumatic cerebral contusions: characterization and risk factors","volume":"67","author":"White","year":"2009","journal-title":"J Trauma"},{"key":"10.1007\/s13311-023-01389-x_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.clineuro.2021.107079","article-title":"Establishment and validation of a prediction model for intraparenchymal hematoma expansion in patients with cerebral contusion: a reliable Nomogram","volume":"212","author":"Zhu","year":"2022","journal-title":"Clin Neurol Neurosurg"},{"key":"10.1007\/s13311-023-01389-x_bib57","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s12883-023-03112-x","article-title":"Classification, risk factors, and outcomes of patients with progressive hemorrhagic injury after traumatic brain injury","volume":"23","author":"Wang","year":"2023","journal-title":"BMC Neurol"},{"key":"10.1007\/s13311-023-01389-x_bib58","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1227\/01.NEU.0000197101.68538.E6","article-title":"Acute traumatic intraparenchymal hemorrhage: risk factors for progression in the early post-injury period.","volume":"58","author":"Chang","year":"2006","journal-title":"Neurosurgery"},{"key":"10.1007\/s13311-023-01389-x_bib59","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1007\/s12028-022-01609-w","article-title":"Time course and clinical significance of hematoma expansion in moderate-to-severe traumatic brain injury: an observational cohort study","volume":"38","author":"Fletcher-Sandersj\u00f6\u00f6","year":"2023","journal-title":"Neurocrit Care"},{"key":"10.1007\/s13311-023-01389-x_bib60","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1089\/neu.2007.0442","article-title":"Post-operative expansion of hemorrhagic contusions after unilateral decompressive hemicraniectomy in severe traumatic brain injury","volume":"25","author":"Flint","year":"2008","journal-title":"J Neurotrauma"},{"key":"10.1007\/s13311-023-01389-x_bib61","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/3-211-30714-1_7","article-title":"CT prediction of contusion evolution after closed head injury: the role of pericontusional edema","volume":"96","author":"Beaumont","year":"2006","journal-title":"Acta Neurochir Suppl"},{"key":"10.1007\/s13311-023-01389-x_bib62","doi-asserted-by":"crossref","first-page":"377","DOI":"10.4103\/0028-3886.28109","article-title":"Expanding traumatic intracerebral contusion\/hematoma","volume":"54","author":"Yadav","year":"2006","journal-title":"Neurol India"},{"key":"10.1007\/s13311-023-01389-x_bib63","first-page":"525","article-title":"Degree of anticoagulation, but not warfarin use itself, predicts adverse outcomes after traumatic brain injury in elderly trauma patients","volume":"63","author":"Pieracci","year":"2007","journal-title":"J Trauma"},{"key":"10.1007\/s13311-023-01389-x_bib64","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s00701-021-05066-w","article-title":"Are oral anticoagulants a risk factor for mild traumatic brain injury progression? A single-center experience focused on of direct oral anticoagulants and vitamin K antagonists","volume":"164","author":"Della Pepa","year":"2002","journal-title":"Acta Neurochir (Wien)"},{"key":"10.1007\/s13311-023-01389-x_bib65","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1080\/02699052.2021.1975196","article-title":"Pre-injury chronic alcohol abuse predicts intracranial hemorrhagic progression, unfavorable clinical outcome, and mortality in severe traumatic brain injury","volume":"35","author":"Svedung Wettervik","year":"2021","journal-title":"Brain Inj"},{"key":"10.1007\/s13311-023-01389-x_bib66","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s12028-019-00898-y","article-title":"Comparison of traumatic intracranial hemorrhage expansion and outcomes among patients on direct oral anticoagulants versus vitamin k antagonists","volume":"32","author":"Shin","year":"2020","journal-title":"Neurocrit Care"},{"key":"10.1007\/s13311-023-01389-x_bib67","doi-asserted-by":"crossref","DOI":"10.1097\/TA.0000000000001995","article-title":"The novel oral anticoagulants (NOACs) have worse outcomes compared to warfarin in patients with intracranial hemorrhage after TBI","author":"Zeeshan","year":"2018","journal-title":"J Trauma Acute Care Surg"},{"key":"10.1007\/s13311-023-01389-x_bib68","article-title":"Prediction of intraparenchymal hemorrhage progression and neurologic outcome in traumatic brain injury patients using radiomics score and clinical parameters","volume":"12","author":"Shih","year":"2002","journal-title":"Diagnostics (Basel)"},{"key":"10.1007\/s13311-023-01389-x_bib69","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1089\/neu.2015.4062","article-title":"Contusion contrast extravasation depicted on multidetector computed tomography angiography predicts growth and mortality in traumatic brain contusion","volume":"33","author":"Rosa","year":"2016","journal-title":"J Neurotrauma"},{"key":"10.1007\/s13311-023-01389-x_bib70","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1227\/01.NEU.0000156200.76331.7A","article-title":"Factors associated with neurological outcome and lesion progression in traumatic subarachnoid hemorrhage patients","volume":"56","author":"Chieregato","year":"2005","journal-title":"Neurosurgery"},{"key":"10.1007\/s13311-023-01389-x_bib71","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s10143-010-0251-z","article-title":"D-dimer as a predictor of progressive hemorrhagic injury in patients with traumatic brain injury: analysis of 194 cases","volume":"33","author":"Tian","year":"2010","journal-title":"Neurosurg Rev."},{"key":"10.1007\/s13311-023-01389-x_bib72","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22105132","article-title":"When the blood hits your brain: the neurotoxicity of extravasated blood","volume":"22","author":"Stokum","year":"2021","journal-title":"Int J Mol Sci."},{"key":"10.1007\/s13311-023-01389-x_bib73","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1016\/S0140-6736(19)32233-0","article-title":"CRASH-3 trial collaborators. Effects of tranexamic acid on death, disability, vascular occlusive events and other morbidities in patients with acute traumatic brain injury (CRASH-3): a randomised, placebo-controlled trial","volume":"394","year":"2019","journal-title":"Lancet"},{"key":"10.1007\/s13311-023-01389-x_bib74","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1001\/jama.2020.8958","article-title":"Effect of out-of-hospital tranexamic acid vs placebo on 6-month functional neurologic outcomes in patients with moderate or severe traumatic brain injury","volume":"324","author":"Rowell","year":"2020","journal-title":"JAMA"},{"key":"10.1007\/s13311-023-01389-x_bib75","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1089\/neu.2009.1021","article-title":"Key role of sulfonylurea receptor 1 in progressive secondary hemorrhage after brain contusion","volume":"26","author":"Simard","year":"2009","journal-title":"J Neurotrauma"},{"key":"10.1007\/s13311-023-01389-x_bib76","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1097\/NEN.0b013e3181fbf6d6","article-title":"Glibenclamide reduces hippocampal injury and preserves rapid spatial learning in a model of traumatic brain injury","volume":"69","author":"Patel","year":"2010","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1007\/s13311-023-01389-x_bib77","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1089\/neu.2018.5986","article-title":"Sulfonylurea receptor 1, transient receptor potential cation channel subfamily M member 4, and kir6.2:role in hemorrhagic progression of contusion","volume":"36","author":"Gerzanich","year":"2019","journal-title":"J Neurotrauma"},{"key":"10.1007\/s13311-023-01389-x_bib78","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222111899","article-title":"Sulfonylurea receptor 1 in central nervous system injury: an updated review","volume":"22","author":"Jha","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1007\/s13311-023-01389-x_bib79","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1089\/neu.2014.3706","article-title":"Sulfonylurea receptor 1 in humans with post-traumatic brain contusions","volume":"32","author":"Mart\u00ednez-Valverde","year":"2015","journal-title":"J Neurotrauma"},{"key":"10.1007\/s13311-023-01389-x_bib80","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1097\/CCM.0000000000005749","article-title":"Precision effects of glibenclamide on MRI endophenotypes in clinically relevant murine traumatic brain injury","volume":"51","author":"Zusman","year":"2023","journal-title":"Crit Care Med"},{"key":"10.1007\/s13311-023-01389-x_bib81","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1089\/neu.2020.7421","article-title":"Glibenclamide treatment in traumatic brain injury: operation brain trauma therapy","volume":"38","author":"Jha","year":"2021","journal-title":"J Neurotrauma"},{"key":"10.1007\/s13311-023-01389-x_bib82","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.wneu.2017.01.103","article-title":"Effects of oral glibenclamide on brain contusion volume and functional outcome of patients with moderate and severe traumatic brain injuries: a randomized double-blind placebo-controlled clinical trial","volume":"101","author":"Khalili","year":"2017","journal-title":"World Neurosurg"},{"key":"10.1007\/s13311-023-01389-x_bib83","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.neuroscience.2014.04.040","article-title":"Glibenclamide reduces secondary brain damage after experimental traumatic brain injury","volume":"272","author":"Zweckberger","year":"2014","journal-title":"Neuroscience"},{"key":"10.1007\/s13311-023-01389-x_bib84","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1089\/neu.2016.4491","article-title":"Glibenclamide attenuates blood-brain barrier disruption in adult mice after traumatic brain injury","volume":"34","author":"Xu","year":"2017","journal-title":"J Neurotrauma"},{"key":"10.1007\/s13311-023-01389-x_bib85","doi-asserted-by":"crossref","first-page":"6512","DOI":"10.1523\/JNEUROSCI.21-17-06512.2001","article-title":"Cell swelling and a nonselective cation channel regulated by internal Ca2+ and ATP in native reactive astrocytes from adult rat brain","volume":"21","author":"Chen","year":"2001","journal-title":"J Neurosci"},{"key":"10.1007\/s13311-023-01389-x_bib86","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/nm1390","article-title":"Newly expressed SUR1-regulated NC(Ca-ATP) channel mediates cerebral edema after ischemic stroke","volume":"12","author":"Simard","year":"2006","journal-title":"Nat Med"},{"key":"10.1007\/s13311-023-01389-x_bib87","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1089\/neu.2016.4696","article-title":"Glibenclamide produces region-dependent effects on cerebral edema in a combined injury model of traumatic brain injury and hemorrhagic shock in mice","volume":"35","author":"Jha","year":"2018","journal-title":"J Neurotrauma"},{"key":"10.1007\/s13311-023-01389-x_bib88","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1089\/neu.2015.4133","article-title":"Synthesis of findings, current investigations, and future directions: operation brain trauma therapy","volume":"33","author":"Kochanek","year":"2016","journal-title":"J Neurotrauma"},{"key":"10.1007\/s13311-023-01389-x_bib89","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1089\/neu.2019.6538","article-title":"Magnetic resonance imaging pilot study of intravenous glyburide in traumatic brain injury","volume":"37","author":"Eisenberg","year":"2020","journal-title":"J Neurotrauma"},{"key":"10.1007\/s13311-023-01389-x_bib90","doi-asserted-by":"crossref","first-page":"e255","DOI":"10.1097\/CCM.0000000000002079","article-title":"Sulfonylurea receptor-1: a novel biomarker for cerebral edema in severe traumatic brain injury","volume":"45","author":"Jha","year":"2017","journal-title":"Crit Care Med"},{"key":"10.1007\/s13311-023-01389-x_bib91","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1089\/neu.2020.7501","article-title":"Cerebrospinal fluid sulfonylurea receptor-1 is associated with intracranial pressure and outcome after pediatric TBI: an exploratory analysis of the cool kids trial","volume":"38","author":"Zusman","year":"2021","journal-title":"J Neurotrauma"},{"key":"10.1007\/s13311-023-01389-x_bib92","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1136\/jnnp-2017-317741","article-title":"Regionally clustered ABCC8 polymorphisms in a prospective cohort predict cerebral oedema and outcome in severe traumatic brain injury","volume":"89","author":"Jha","year":"2018","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1007\/s13311-023-01389-x_bib93","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s12028-016-0309-z","article-title":"ABCC8 Single nucleotide polymorphisms are associated with cerebral edema in severe TBI","volume":"26","author":"Jha","year":"2017","journal-title":"Neurocrit Care"},{"key":"10.1007\/s13311-023-01389-x_bib94","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1089\/neu.2018.6124","article-title":"Downstream TRPM4 polymorphisms are associated with intracranial hypertension and statistically interact with ABCC8 polymorphisms in a prospective cohort of severe traumatic brain injury","volume":"36","author":"Jha","year":"2019","journal-title":"J Neurotrauma"},{"key":"10.1007\/s13311-023-01389-x_bib95","doi-asserted-by":"crossref","DOI":"10.5812\/traumamon.25113","article-title":"Evaluation of the effect of glibenclamide in patients with diffuse axonal injury due to moderate to severe head trauma","volume":"21","author":"Zafardoost","year":"2016","journal-title":"Trauma Mon"},{"key":"10.1007\/s13311-023-01389-x_bib96","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1016\/S1474-4422(16)30196-X","article-title":"Safety and efficacy of intravenous glyburide on brain swelling after large hemispheric infarction (GAMES-RP): a randomised, double-blind, placebo-controlled phase 2 trial","volume":"15","author":"Sheth","year":"2016","journal-title":"Lancet Neurol"},{"key":"10.1007\/s13311-023-01389-x_bib97","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1161\/STROKEAHA.113.003352","article-title":"Pilot study of intravenous glyburide in patients with a large ischemic stroke","volume":"45","author":"Sheth","year":"2014","journal-title":"Stroke"}],"container-title":["Neurotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13311-023-01389-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13311-023-01389-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747923019918?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747923019918?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13311-023-01389-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T07:19:30Z","timestamp":1761808770000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878747923019918"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":97,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["S1878747923019918"],"URL":"https:\/\/doi.org\/10.1007\/s13311-023-01389-x","relation":{},"ISSN":["1878-7479"],"issn-type":[{"value":"1878-7479","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Glibenclamide for Brain Contusions: Contextualizing a Promising Clinical Trial Design that Leverages an Imaging-Based TBI Endotype","name":"articletitle","label":"Article Title"},{"value":"Neurotherapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1007\/s13311-023-01389-x","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2023 The Author(s). Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}